Cargando…
Public spending on orphan medicines: a review of the literature
BACKGROUND AND OBJECTIVE: Little is known about how much public payers spend on orphan medicines. This study aimed at identifying information on orphan medicine expenditure incurred by public payers that was published in literature globally and at possibly synthesising their shares as portion of the...
Autores principales: | Gombocz, Margit, Vogler, Sabine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552556/ https://www.ncbi.nlm.nih.gov/pubmed/33062285 http://dx.doi.org/10.1186/s40545-020-00260-0 |
Ejemplares similares
-
Price and reimbursement for orphan medicines and managed entry agreements: does Italy need a framework?
por: Jommi, Claudio, et al.
Publicado: (2021) -
Public preferences for government spending in Canada
por: Ramji, Sabrina, et al.
Publicado: (2012) -
Trends in orphan drug use and spending among children and adolescents during 2010–2020 in Korea
por: Oh, Jung Yeon, et al.
Publicado: (2022) -
Science policy and public spending
por: Llewellyn Smith, Christopher Hubert, et al.
Publicado: (1985) -
Self-organization in Slovenian public spending
por: Joksimović, Jelena, et al.
Publicado: (2023)